U.S. Physical Therapy (NYSE:USPH) Stock Price Target Raised at Barrington Research

U.S. Physical Therapy (NYSE:USPH) had its target price raised by Barrington Research from $110.00 to $122.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

USPH has been the subject of a number of other reports. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. JPMorgan Chase & Co. raised their price objective on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, September 11th. Finally, Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $104.25.

U.S. Physical Therapy Price Performance

Shares of U.S. Physical Therapy stock traded up $0.87 on Friday, hitting $99.47. 148,432 shares of the company traded hands, compared to its average volume of 191,591. The firm’s 50-day simple moving average is $86.32 and its 200 day simple moving average is $77.39. The company has a current ratio of 1.42, a quick ratio of 1.42 and a debt-to-equity ratio of 0.56. The company has a market cap of $1.48 billion, a P/E ratio of -73.68, a P/E/G ratio of 2.71 and a beta of 1.16. U.S. Physical Therapy has a 12-month low of $58.19 and a 12-month high of $101.80.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, November 5th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.76 by $0.04. The firm had revenue of $222.56 million during the quarter, compared to analysts’ expectations of $214.48 million. U.S. Physical Therapy had a return on equity of 10.19% and a net margin of 3.60%. The company’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.66 EPS. Analysts expect that U.S. Physical Therapy will post 2.87 earnings per share for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 11th. Shareholders of record on Monday, November 16th will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Monday, November 16th. This represents a $1.84 dividend on an annualized basis and a yield of 1.8%. U.S. Physical Therapy’s dividend payout ratio is presently -136.30%.

Institutional Investors Weigh In On U.S. Physical Therapy

A number of large investors have recently made changes to their positions in the business. BlackRock Inc. purchased a new stake in U.S. Physical Therapy in the second quarter worth $155,505,000. Copeland Capital Management LLC increased its position in U.S. Physical Therapy by 11.8% during the 3rd quarter. Copeland Capital Management LLC now owns 940,528 shares of the company’s stock valued at $80,632,000 after purchasing an additional 98,984 shares during the period. Bahl & Gaynor LLC raised its holdings in U.S. Physical Therapy by 3.2% in the 3rd quarter. Bahl & Gaynor LLC now owns 889,265 shares of the company’s stock worth $76,237,000 after purchasing an additional 27,691 shares in the last quarter. William Blair Investment Management LLC raised its holdings in U.S. Physical Therapy by 50.9% in the 3rd quarter. William Blair Investment Management LLC now owns 659,509 shares of the company’s stock worth $56,540,000 after purchasing an additional 222,513 shares in the last quarter. Finally, Bank of America Corp DE raised its holdings in U.S. Physical Therapy by 10.9% in the 1st quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock worth $41,574,000 after purchasing an additional 54,656 shares in the last quarter.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics across the United States. Its clinics provide rehabilitation for musculoskeletal conditions, orthopedic injuries, sports-related injuries and recovery following surgery, along with other therapy services tailored to patients’ needs. Founded in 1990 and headquartered in Houston, Texas, the company also provides industrial injury prevention and related services to employers. Its clinic network serves communities in multiple states, with care delivered through local therapy practices.